logotype

Category: Canine Health

Golden retriever lying on a veterinary exam table during an ultrasound procedure, with a technician and ultrasound monitor visible in the background

Canine Kidney Ultrasound: Technique, Transducer Selection, and What to Look For

Renal ultrasound is one of those skills that looks deceptively straightforward on paper—until you’re wedged between a squirming dog, a dimly lit room, and limited acoustic windows that make every image harder to acquire. Done well, it’s one of the most clinically valuable tools in your diagnostic arsenal. Done carelessly, it’s an expensive way to not find a kidney. 

Whether you’re building your ultrasound confidence from scratch or looking for a technique refresher, this guide covers the essentials of canine kidney scanning: patient prep, transducer selection, systematic evaluation, and what normal actually looks like—so you’ll recognize when something isn’t. 

Step One: Give Yourself a Fighting Chance with Patient Prep 

Before a single image is acquired, how well you prepare the patient will determine how good your scan can possibly be. No amount of technical skill compensates for poor acoustic contact, and nothing undermines acoustic contact faster than an unclipped coat. 

When scanning canine kidneys, clip the hair over the last two to three intercostal spaces and extend the clip dorsally. This step is non-negotiable. Trying to image through an intact coat introduces artifact and signal loss that no transducer can overcome—and it turns what should be a focused diagnostic exam into an exercise in frustration. 

Once clipped, apply generous acoustic coupling gel and position your patient in dorsal or lateral recumbency depending on your preferred approach. Taking a moment to get comfortable before you start scanning pays off: ergonomics matter when you’re holding a transducer steady and interpreting images simultaneously. 

Transducer Selection: Matching the Tool to the Patient 

Transducer choice shapes the quality of everything you see. The two variables to get right are footprint size and frequency, and both are largely determined by the patient in front of you and the imaging window you’re working through. 

Footprint: Intercostal vs. Subcostal Approach 

For intercostal imaging, a small-footprint transducer is essential. It fits cleanly between the ribs without the rib-shadow interference that wider probes create, giving you the access you need without compromising image quality. For subcostal views, spatial constraints relax and a larger curved array probe is appropriate—one that delivers a wider field of view and better penetration for deeper structures. 

Frequency: Balancing Depth and Resolution 

In most dogs, a 5–10 MHz transducer covers the range well. Higher frequencies give better spatial resolution at shallower depths; lower frequencies penetrate more deeply at some cost to fine structural detail. Patient size should guide your selection: 

  • Giant breeds: Plan on greater tissue depth. Lower frequencies within your range will be necessary for adequate penetration. 
  • Average-sized dogs: A 5–10 MHz transducer handles most patients comfortably. 
  • Cats and small dogs: Higher frequencies are required for the resolution needed to image small kidneys. These patients also tend to be less cooperative, which adds its own dimension to the challenge. 

Getting frequency right from the start means less time chasing a blurry image and more time actually interpreting one. 

The SonoView® ultrasound system’s wireless, multi-array design—combining curved array, phased array, and linear array in one unit—gives you the flexibility to adapt your approach across patient sizes without changing equipment. Learn more about the SonoView ultrasound system. 

Scanning Technique: Be Systematic 

Once your patient is prepped and your transducer is in position, systematic evaluation is everything. The most common scanning error isn’t a technical failure—it’s an incomplete one. 

Fully evaluate each kidney in both long axis and short axis—and importantly, “long” and “short” here are relative to the kidney itself, not the spine. Renal orientation varies between patients, and if you’re aligning your imaging planes to the spine rather than the organ, you’ll miss lesions that only reveal themselves off-axis. 

Work through each kidney methodically: every cortical surface, every medullary pyramid, the renal pelvis, and the hilus. Subtle findings—early cysts, small masses, focal infarcts—are exactly the things that disappear when you rush. When something looks unusual, fan through it in multiple planes before moving on. Confirming whether a finding is real, incidental, or artifact takes an extra thirty seconds and saves a great deal of diagnostic uncertainty later. 

Don’t Skip the Hilus 

The renal hilus—where the vasculature, ureter, and renal pelvis converge—deserves deliberate attention and is easy to gloss over in a rushed exam. Dilation of the proximal ureter, vascular irregularities, and pelvic changes can all be detected here when you look for them specifically. 

Assessing Kidney Size: Radiographs and Ultrasound Each Have a Role 

Renal size assessment draws on both modalities, and knowing the standards for each keeps your diagnostic picture complete. 

Radiographic Sizing: The L2 Standard 

On ventrodorsal radiographs, the gold standard for renal sizing in dogs is comparing each kidney to the length of the L2 vertebral body. Normal canine kidneys measure approximately 2.5 to 3.5 times the length of L2. Anything outside that range warrants follow-up. Kidneys that are too small suggest chronic disease; kidneys that are too large may indicate infiltrative disease, obstruction, or neoplasia. 

Ultrasound Sizing: Architecture Matters as Much as Dimensions 

On ultrasound, size is only one part of what you’re evaluating. Architecture is equally informative—sometimes more so. The kidneys should be symmetrical in size and shape, with smooth, well-defined capsular margins. Asymmetry between the two kidneys, irregular or indistinct margins, or disrupted internal organization are all findings that warrant closer investigation and, often, specialist consultation. 

Always compare left and right. A kidney that appears unremarkable in isolation may look significantly abnormal when placed next to its counterpart. 

The SonoView® ultrasound system is designed for in-clinic use with expert backup when you need it—so you can evaluate complex cases confidently without sending every patient out. Request more information on the SonoView proctored model. 

Normal Ultrasound Findings: What You Should Expect to See 

Reliable identification of abnormal findings starts with a thorough understanding of normal ones. Healthy canine kidneys on ultrasound should be symmetrical, smooth-margined, and well-organized internally. Here’s what to expect in a normal patient. 

Corticomedullary Contrast 

There should be a clear, visible difference in echogenicity between the cortex and the medulla. The cortex appears more echogenic—brighter—than the medulla. This corticomedullary distinction is one of the most reliable markers of normal renal architecture on ultrasound. When it’s lost, blurred, or reversed, you’re looking at a finding that warrants attention. Conditions such as chronic kidney disease, glomerulonephritis, and various infiltrative processes can all disrupt this boundary in characteristic ways. 

The Renal Pelvis 

The renal pelvis may be visible on your scan, and in a normal patient that’s expected—as long as it remains unobtrusive. In normal dogs, the renal pelvis measures less than 2 mm. If it’s within that range and unremarkable in appearance, note it and move on. 

If the renal pelvis is enlarged or prominent, that finding warrants investigation. Pelvic dilation can indicate hydronephrosis, obstruction, infection, or pyelonephritis—none of which should go unaddressed. 

Which brings us to the one rule in this guide that is entirely non-negotiable: always scan the bladder. If the renal pelvis looks abnormal, scan the bladder. If everything looks normal, scan the bladder anyway. Hydronephrosis, ureterolithiasis, and lower urinary tract disease often announce themselves—or at least hint at themselves—downstream. Skipping the bladder means skipping half the story. Just kidding about the “if”—always scan the bladder. 

Building Ultrasound Confidence In-Clinic: Where the SonoView® Ultrasound System Comes In 

One of the most persistent barriers to in-house ultrasound isn’t equipment—it’s confidence. Many general practitioners are capable of more than they give themselves credit for, but without structured feedback during the learning curve, skills plateau or go underused. 

The SonoView ultrasound system is designed to address that gap directly. Rather than leaving clinicians to build proficiency on their own, the SonoView system pairs advanced imaging hardware with a proctored learning model: remote expert support available via phone call or tele-presence as you scan your own patients in your own clinic. 

That means you’re not choosing between developing skills and serving patients—you’re doing both simultaneously. You maintain your normal patient load, generate revenue from in-house ultrasound services from day one, avoid the cost and disruption of off-site training, and build genuine diagnostic proficiency over time with expert guidance behind you. 

The SonoView system is available in two configurations: 

  • SonoView Mini-C: USB-powered, designed for point-of-care ultrasound (POCUS) and musculoskeletal imaging with Color Doppler. 
  • SonoView Nano: Wireless system combining curved array, phased array, and linear array in one unit. Operates on iOS, Android, and Windows. 

For general practitioners who perform renal evaluations regularly—or who want to expand into abdominal ultrasound—having reliable, supported in-house imaging changes what’s possible for patients and practice alike. 

Ready to bring proctored ultrasound into your clinic? Learn more about the SonoView ultrasound system. Or read more ultrasound content on the Zomedica blog. 

Quick Reference: Canine Renal Ultrasound at a Glance 

A practical summary of the key technique points covered in this guide: 

  • Prep: Clip the last 2–3 intercostal spaces and extend dorsally before scanning. 
  • Intercostal approach: Use a small-footprint transducer. Subcostal: curved array is appropriate. 
  • Frequency: 5–10 MHz for most dogs. Lower for giant breeds. Higher for cats and small dogs. 
  • Evaluate fully: Long and short axis, oriented to the kidney—not the spine. 
  • Radiographic sizing: Normal kidneys measure 2.5–3.5 × the L2 vertebral body length. 
  • Normal architecture: Symmetrical, smooth margins, distinct corticomedullary contrast. 
  • Renal pelvis: Less than 2 mm in normal dogs. Enlargement warrants investigation. 
  • Always: Scan the bladder. 

©2026 Zomedica Inc. All rights reserved. SONOVIEW is a registered trademark of Zomedica Inc. 

Disclaimer: The information provided on this blog is for general informational and educational purposes only. It is not intended as medical advice and should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before making any health‑related decisions.   

Blog Banner for Website Content (19)

Canine Pancreatitis Diagnosis: Point-of-Care Testing Case Study

Acute pancreatitis in dogs can present with vague clinical signs that overlap with many gastrointestinal conditions, making rapid, accurate diagnosis challenging in general practice. This case study, provided by Dr. Deborah Greco, demonstrates how point-of-care pancreatic lipase testing using the TRUFORMA® diagnostic system enabled immediate diagnosis and successful outpatient management of acute pancreatitis in a 12-year-old Yorkshire Terrier, avoiding costly emergency referral while providing excellent patient care. 

Case Presentation: Complex Medical History with Acute GI Signs

Patient Background 

Signalment: 12-year-old spayed female Yorkshire Terrier named Lola  

Presenting Complaints: Large bowel diarrhea with mucus, vomiting, anorexia, lethargy 

Relevant Medical History: 

  • Hypothyroidism (1 year duration) – managed with levothyroxine 0.2 mg BID 
  • Hyperadrenocorticism (8 months duration) – treated with trilostane 20 mg BID 
  • Atopic dermatitis – managed with monthly Cytopoint injections and topical therapy 
  • Chronic GI sensitivity – maintained on hydrolyzed protein diet 

Initial Clinical Course 

Timeline of Events: 

  • Day 1: Normal eating, then midnight vomiting followed by four episodes of mucoid diarrhea 
  • Weekend: Owner initiated metronidazole, but patient stopped eating and drinking 
  • Urgent care visit: Received maropitant, B12 injection, and Entyce 
  • Presentation day: Continued anorexia, lethargy, weakness, and stumbling 

Physical Examination Findings: 

  • Dehydration: 5-6% based on tacky mucous membranes 
  • Dermatologic lesions: Pyoderma on ventral abdomen and left neck 
  • General condition: Lethargic and weak with unsteady gait 
  • Otherwise unremarkable physical examination 

Diagnostic Approach: Point-of-Care Testing Strategy

Laboratory Testing Protocol 

Minimum Database Collected: 

  • Complete blood count (CBC) 
  • Comprehensive serum chemistry profile 
  • TRUFORMA cPL (canine pancreatic lipase) – point-of-care testing 

Key Laboratory Results 

Hematology Findings (Suggesting Inflammation): 

  • WBC: 11.60 K/µL (elevated, reference 5.05-16.76) 
  • Monocytes: 1.18 K/µL (elevated, reference 0.16-1.12) – indicating inflammatory response 
  • Platelets: 89 K/µL (thrombocytopenia, reference 148-484) – possible consumption 
  • Neutrophils: 68.8% suggesting inflammatory process 

Chemistry Profile Abnormalities: 

  • ALT: 136 U/L (elevated, reference 10-125) 
  • ALP: 399 U/L (elevated, reference 23-212) 
  • BUN: 41 mg/dL (elevated, reference 7-27) – likely dehydration-related 
  • Globulin: 5.0 g/dL (elevated, reference 2.5-4.5) 
  • Cholesterol: 334 mg/dL (elevated, reference 110-320) 

Critical Finding – TRUFORMA cPL Result: 

  • Initial cPL: 1190 µg/L (significantly elevated) 
  • Reference range: <200 µg/L normal, >400 µg/L consistent with pancreatitis 

TRUFORMA Diagnostic System: Enabling Rapid Decision-Making

Point-of-Care Testing Advantages 

Immediate Clinical Benefits: 

  • 15-minute results allowed same-visit treatment planning 
  • Quantitative measurement provided baseline for monitoring therapy 
  • Avoided referral delay and expense of emergency hospitalization 
  • Enabled confident outpatient management with appropriate monitoring 

Technology Advantages: 

  • High accuracy correlating with Texas A&M Spec® cPL  
  • User-friendly operation requiring minimal training 
  • Consistent results allowing precise monitoring and unaffected by sample quality  
  • Multi-test platform for comprehensive point-of-care diagnostics 

Clinical Decision Impact 

Immediate Treatment Decisions Based on Results: 

  • Confirmed pancreatitis diagnosis justified specific dietary and medical management 
  • Baseline cPL value established for therapeutic monitoring 
  • Outpatient management deemed appropriate based on clinical status and owner compliance 
  • Referral avoided saving client significant expense while maintaining quality care 

Treatment Protocol and Monitoring Strategy

Initial Management Plan 

Immediate Interventions: 

  • Subcutaneous fluid therapy: 100 mL administered in-clinic 
  • Home fluid therapy: Owner-administered SQ fluids for continued hydration 
  • Dietary modification: Switched to Purina ProPlan EN gastroenteric low-fat diet 
  • Medication adjustments: Discontinued metronidazole, continued trilostane and levothyroxine 
  • Symptomatic support: Fortiflora prescribed for diarrhea management 

Monitoring Protocol: 

  • Serial cPL testing using TRUFORMA diagnostic system 
  • Clinical assessment for appetite, hydration, and energy level 
  • Owner communication for home monitoring and compliance 

Treatment Response Monitoring 

Day 3 Follow-up: 

  • TRUFORMA cPL: Decreased to 900 µg/L (25% reduction) 
  • Clinical improvement: Some appetite return, better hydration 
  • Continued management: SQ fluids and dietary therapy 

One Week Follow-up: 

  • TRUFORMA cPL: Further decreased to 600 µg/L (50% reduction from initial) 
  • Complications addressed: Worsening dermatitis managed with Cytopoint injection 
  • Additional treatments: Enrofloxacin for pyoderma, Claro for otitis externa 
  • Laboratory normalization: Liver enzymes and WBC returning to normal ranges 

Eight Days Later: 

  • TRUFORMA cPL: 314 µg/L (74% reduction from initial value) 
  • Clinical resolution: Normal appetite, voluntary water consumption, excellent energy 
  • Laboratory normalization: Complete resolution of liver enzyme elevation and leukocytosis 
  • Full recovery: Patient returned to normal activity and demeanor 

Case Study Analysis: Clinical Lessons

Diagnostic Value of Serial cPL Monitoring 

Quantitative Trend Analysis: 

  • Initial diagnosis: cPL 1190 µg/L confirmed acute pancreatitis 
  • Early response: cPL 900 µg/L (Day 3) showed treatment effectiveness 
  • Continued improvement: cPL 600 µg/L (Day 7) supported ongoing management 
  • Near resolution: cPL 314 µg/L (Day 15) indicated successful treatment 

Clinical Correlation: The consistent correlation between decreasing cPL values and clinical improvement validated the treatment approach and provided objective evidence of recovery progress. 

Benefits of Point-of-Care Testing 

Practice Management Advantages: 

  • Immediate results enabled same-visit treatment planning 
  • Cost-effective care avoided expensive emergency referral 
  • Client confidence improved through rapid diagnosis and monitoring 
  • Quality outcomes achieved through appropriate treatment and monitoring 

Patient Care Benefits: 

  • Rapid diagnosis prevented delayed treatment 
  • Appropriate therapy initiated immediately based on objective data 
  • Successful monitoring ensured treatment effectiveness 
  • Outpatient management reduced stress and maintained quality of life 

TRUFORMA Diagnostic System: Advanced Point-of-Care Technology

The TRUFORMA diagnostic system brings laboratory-quality pancreatic testing directly into veterinary clinics using innovative bulk acoustic wave technology. This advanced system provides quantitative cPL results in 15 minutes, enabling immediate diagnosis and treatment decisions for optimal patient care. 

Key Technology Features: 

  • 15-minute turnaround time for immediate clinical decision-making 
  • Bulk acoustic wave technology eliminates interference from hemolysis or lipemia 
  • Quantitative results enable precise treatment monitoring and trend analysis 
  • Reference laboratory correlation >0.95 for reliable accuracy 
  • Multi-analyte platform supporting comprehensive diagnostic testing 
  • Simple operation requiring minimal training for consistent results 

Transform your practice’s diagnostic capabilities with rapid, accurate pancreatic testing that enables successful outpatient management of pancreatitis cases like demonstrated in this real-world case study provided by Dr. Deborah Greco. 

Visit zomedicadev.com to discover how the TRUFORMA diagnostic system can revolutionize your approach to gastrointestinal disease diagnosis and management.